|
|
||||||||
Section of Cardiovascular Medicine, Department of Internal Medicine and Cardiovascular Nuclear Imaging Laboratory, Yale University School of Medicine, New Haven, Connecticut
Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
Correspondence: For correspondence and reprints contact: Barry L. Zaret, MD, Chief Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar Street, FMP 3, New Haven, CT 06510.
ABSTRACT
Cardiac peak power, a contractility index based upon instantaneous changes in intracavitary pressure and systolic peak flow, was measured at rest and during supine exercise in 26 patients with coronary artery disease and 8 healthy subjects. The pathophysiological significance of this index was compared with left ventricular ejection fraction (LVEF) during exercise. Cardiac peak power, ejection fraction, end-diastolic volume, stroke volume, cardiac output and systemic vascular resistance were measured at rest, during three stages of supine bicycle ergometry and two stages of recovery. Cardiac peak power increased continuously in healthy subjects, from 5.4 ± 0.8 W/ml at rest to 11.4 ± 3.1 W/ml at peak exercise, p < 0.001. In patients, peak power increased initially, reached a plateau in stage 2, and subsequently remained unchanged in stage 3 (5.6 ± 2 versus 5.6 ± 1.6 W/ml, p = ns). Ejection fraction demonstrated a flat response during exercise in patients, contrasting with a 42% increase in cardiac peak power. The lack of increase in ejection fraction was attributed to its dependence on afterload. Peak power showed no correlation with systemic vascular resistance (r = 0.01, p = ns). In a subgroup of patients with low resting LVEF (LVEF = 26% ± 7%), peak power increased 70% during exercise, from 2.0 ± 0.7 to 3.5 ± 1.7 W/ml, p < 0.05, in contrast to a flat ejection fraction response. Thus, cardiac peak power, a relatively after load-independent index of left ventricular performance and contractility can be obtained noninvasively during exercise.
This article has been cited by other articles:
![]() |
P. Segers, V. Tchana-Sato, H. A. Leather, B. Lambermont, A. Ghuysen, J.-M. Dogne, P. Benoit, P. Morimont, P. F. Wouters, P. Verdonck, et al. Determinants of left ventricular preload-adjusted maximal power Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2295 - H2301. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Segers, H. A. Leather, P. Verdonck, Y.-Y. Sun, and P. F. Wouters Preload-adjusted maximal power of right ventricle: contribution of end-systolic P-V relation intercept Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1681 - H1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cohen-Solal, J.Y. Tabet, D. Logeart, P. Bourgoin, M. Tokmakova, and M. Dahan A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure Eur. Heart J., May 2, 2002; 23(10): 806 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chen, M. Nakayama, M. Talbot, E. Nevo, B. Fetics, G. Gerstenblith, L. C. Becker, and D. A. Kass Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1602 - 1609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |